Bangor Savings Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.03M | Buy |
12,051
+885
| +8% | +$190K | 0.22% | 43 |
|
|
2026
Q1 | $2.43M | Sell |
11,166
-555
| -5% | -$123K | 0.19% | 45 |
|
|
2025
Q4 | $2.68M | Sell |
11,721
-216
| -2% | -$49.2K | 0.22% | 44 |
|
|
2025
Q3 | $2.76M | Sell |
11,937
-778
| -6% | -$158K | 0.23% | 43 |
|
|
2025
Q2 | $2.36M | Buy |
12,715
+286
| +2% | +$53.2K | 0.21% | 46 |
|
|
2025
Q1 | $2.6M | Sell |
12,429
-1,645
| -12% | -$320K | 0.25% | 41 |
|
|
2024
Q4 | $2.5M | Buy |
14,074
+39
| +0.3% | +$7.17K | 0.23% | 45 |
|
|
2024
Q3 | $2.77M | Sell |
14,035
-109
| -0.8% | -$20.3K | 0.26% | 44 |
|
|
2024
Q2 | $2.43M | Buy |
14,144
+294
| +2% | +$48.7K | 0.24% | 51 |
|
|
2024
Q1 | $2.52M | Sell |
13,850
-347
| -2% | -$59.8K | 0.26% | 52 |
|
|
2023
Q4 | $2.2M | Sell |
14,197
-574
| -4% | -$83.7K | 0.24% | 56 |
|
|
2023
Q3 | $2.2M | Buy |
14,771
+18
| +0.1% | +$2.64K | 0.26% | 53 |
|
|
2023
Q2 | $1.99M | Buy |
14,753
+306
| +2% | +$44.9K | 0.23% | 62 |
|
|
2023
Q1 | $2.3M | Sell |
14,447
-541
| -4% | -$82.7K | 0.27% | 44 |
|
|
2022
Q4 | $2.42M | Sell |
14,988
-3,783
| -20% | -$580K | 0.29% | 39 |
|
|
2022
Q3 | $2.52M | Sell |
18,771
-1,029
| -5% | -$148K | 0.29% | 41 |
|
|
2022
Q2 | $3.03M | Buy |
+19,800
| New | +$3.03M | 0.33% | 35 |
|
|
2022
Q1 | – | Sell |
-16,524
| Closed | -$2.24M | – | 180 |
|
|
2021
Q4 | $2.24M | Buy |
16,524
+1,284
| +8% | +$152K | 0.21% | 68 |
|
|
2021
Q3 | $1.64M | Buy |
15,240
+3,437
| +29% | +$393K | 0.17% | 81 |
|
|
2021
Q2 | $1.33M | Buy |
11,803
+188
| +2% | +$21.2K | 0.15% | 87 |
|
|
2021
Q1 | $1.26M | Buy |
11,615
+2,053
| +21% | +$220K | 0.15% | 90 |
|
|
2020
Q4 | $1.02M | Sell |
9,562
-1,433
| -13% | -$138K | 0.14% | 91 |
|
|
2020
Q3 | $963K | Buy |
10,995
+634
| +6% | +$59.7K | 0.15% | 91 |
|
|
2020
Q2 | $1.02M | Buy |
10,361
+70
| +0.7% | +$6.16K | 0.16% | 88 |
|
|
2020
Q1 | $784K | Buy |
10,291
+61
| +0.6% | +$5.2K | 0.15% | 89 |
|
|
2019
Q4 | $906K | Buy |
10,230
+2,940
| +40% | +$244K | 0.14% | 90 |
|
|
2019
Q3 | $552K | Sell |
7,290
-180
| -2% | -$12.3K | 0.09% | 115 |
|
|
2019
Q2 | $544K | Buy |
7,470
+171
| +2% | +$13.4K | 0.1% | 110 |
|
|
2019
Q1 | $588K | Buy |
7,299
+625
| +9% | +$51.1K | 0.11% | 107 |
|
|
2018
Q4 | $615K | Sell |
6,674
-206
| -3% | -$18.1K | 0.13% | 105 |
|
|
2018
Q3 | $650K | Buy |
6,880
+23
| +0.3% | +$2.18K | 0.12% | 114 |
|
|
2018
Q2 | $635K | Sell |
6,857
-10
| -0.1% | -$977 | 0.12% | 113 |
|
|
2018
Q1 | $650K | Buy |
6,867
+114
| +2% | +$12.5K | 0.13% | 110 |
|
|
2017
Q4 | $653K | Buy |
6,753
+62
| +0.9% | +$5.84K | 0.13% | 106 |
|
|
2017
Q3 | $594K | Buy |
+6,691
| New | +$509K | 0.12% | 105 |
|
|
2017
Q2 | – | Sell |
-6,394
| Closed | -$417K | – | 138 |
|
|
2017
Q1 | $417K | Buy |
6,394
+142
| +2% | +$8.93K | 0.09% | 106 |
|
|
2016
Q4 | $391K | Sell |
6,252
-38
| -0.6% | -$2.32K | 0.09% | 104 |
|
|
2016
Q3 | $397K | Hold |
6,290
| – | – | 0.09% | 104 |
|
|
2016
Q2 | $389K | Buy |
6,290
+418
| +7% | +$25.5K | 0.1% | 104 |
|
|
2016
Q1 | $335K | Buy |
5,872
+231
| +4% | +$12.9K | 0.08% | 112 |
|
|
2015
Q4 | $335K | Buy |
5,641
+1
| +0% | +$58 | 0.08% | 110 |
|
|
2015
Q3 | $307K | Buy |
5,640
+189
| +3% | +$12.3K | 0.08% | 117 |
|
|
2015
Q2 | $366K | Buy |
5,451
+210
| +4% | +$13.7K | 0.09% | 115 |
|
|
2015
Q1 | $307K | Buy |
5,241
+607
| +13% | +$36.7K | 0.07% | 127 |
|
|
2014
Q4 | $303K | Buy |
4,634
+77
| +2% | +$4.85K | 0.08% | 130 |
|
|
2014
Q3 | $263K | Sell |
4,557
-267
| -6% | -$14.8K | 0.07% | 131 |
|
|
2014
Q2 | $272K | Buy |
+4,824
| New | +$253K | 0.07% | 127 |
|
|
2014
Q1 | – | Sell |
-5,880
| Closed | -$311K | – | 117 |
|
|
2013
Q4 | $311K | Buy |
5,880
+1,291
| +28% | +$63.5K | 0.09% | 121 |
|
|
2013
Q3 | $205K | Buy |
+4,589
| New | +$203K | 0.06% | 127 |
|
Other funds holding ABBV
Bangor Savings Bank's ABBV Position: Q2 2026 in Review
Bangor Savings Bank increased its AbbVie (ABBV) stake by 7.9% in Q2 2026, buying an estimated $190K and bringing the position to 12,051 shares worth $3.03M. The position accounts for 0.22% of the portfolio, ranked #43.
Bangor Savings Bank first reported a position in ABBV in Q3 2013 and has held it in 49 quarters since. The position peaked at $3.03M in Q2 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bangor Savings Bank held 12,051 shares of AbbVie worth $3.03M as of Q2 2026.
- Bangor Savings Bank bought 885 AbbVie shares in Q2 2026, an estimated $190K.
- AbbVie made up 0.22% of Bangor Savings Bank's portfolio in Q2 2026, its #43 holding.
- Bangor Savings Bank first reported a position in AbbVie in Q3 2013 and has held it in 49 quarters since.
- Bangor Savings Bank's AbbVie position peaked at $3.03M in Q2 2022.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.